StonvexLoading…
StonvexStonvexStonvexCore line items from GILD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.96B | $29.44B | $21.52B | $13.75B |
Operating Income | $2.59B | $10.02B | $8.04B | $4.71B |
Net Income | $2.02B | $8.51B | $6.33B | $3.27B |
EPS (Diluted) | $1.61 | $6.78 | $5.04 | $2.61 |
Total Assets | $56.28B | $59.02B | $58.53B | $55.72B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $7.63B | $7.56B | $7.33B | $5.14B |
Free Cash Flow OCF − CapEx | $2.43B | $9.46B | $6.33B | $2.37B |
Shares Outstanding | 1.24B | 1.24B | 1.24B | 1.24B |